ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,989, issued on May 13, was assigned to ASCENDIS PHARMA BONE DISEASES A/S (Hellerup, Denmark).
"Controlled-release PTH compound" was invented by Kennett Sprogoe (Holte, Denmark), Guillaume Maitro (Mannheim, Germany), Mathias Krusch (Hirschhorn, Germany), Thomas Wegge (Heidelberg, Germany), Joachim Zettler (Heidelberg, Germany), Lars Holten-Andersen (Vanlose, Denmark) and David Brian Karpf (Mountain View, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a method of treating or controlling hypoparathyroidism in a human patient by administering to the human patient a pharmaceutical composition comprising a controlled-release ...